A Phase II Clinical Study of BW-20507 in Combination With PEG-IFNα for the Treatment of Hepatitis B
Clinical trial NCT07135349 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07135349
- Sponsor
- Shanghai Argo Biopharmaceutical Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-02
- Primary completion
- 2026-06-07
- Enrollment
- 209
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.